Health
Novel Drug Compound Designed To Treat Respiratory Diseases – Technology Networks
Experts in airway bitter taste receptors and medicinal chemistry collaborate in efforts to advance a treatment for respiratory diseases, that works differently…

Despite the progress made in managing asthma and chronic obstructive pulmonary disease (COPD), poorly controlled symptoms for both respiratory diseases can lead to severe shortness of breath, hospitalizations or even death.
“Only about 50 percent of asthmatics, and an even lower percentage of people with COPD, achieve adequate control of lung inflammation and airway constriction with currently available medications,” said Stephen Liggett, MD, vice dean for research at the University of South Florida…
-
General21 hours ago
Donald Trump and the ghost of Al Capone • Inside Story
-
General14 hours ago
French far-right supporters rally against Le Pen conviction in Paris
-
Business5 hours ago
1 ASX dividend stock down 43% I’d buy right now
-
Business9 hours ago
Battle of the ASX ETFs: Why has VGS outperformed VTS this year?